ResearcherEötvös Loránd UniversityNo recent work listed

Levente Endre Dókus

Verified by OpenAlex author ID (good confidence)As of 11 November 2026

Matched on OpenAlex author ID A5077269369.

Their work

Papers: 2 (first author 1, last author 0)
Trials: 0
Grants: 0
Collaborators: 4

Papers, trials and grants by year

2019: 1 paper · 2020: 1 paper

Papers 2

Phage Display-Based Homing Peptide-Daunomycin Conjugates for Selective Drug Targeting to PANC-1 Pancreatic Cancer. First author DOI 10.3390/pharmaceutics12060576 ↗
[Comparison of therapeutic peptides targeting pancreatic cancer]. Co-author PMID 31821385 ↗

Closest collaborators

The 4 strongest of 4 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

Eszter Lajkó · 2 shared papers, 2019–2020
- Paper Phage Display-Based Homing Peptide-Daunomycin Conjugates for Selective Drug Targeting to PANC-1 Pancreatic Cancer. DOI 10.3390/pharmaceutics12060576 ↗
- Paper [Comparison of therapeutic peptides targeting pancreatic cancer]. PMID 31821385 ↗
Gábor Mező · 2 shared papers, 2019–2020
- Paper Phage Display-Based Homing Peptide-Daunomycin Conjugates for Selective Drug Targeting to PANC-1 Pancreatic Cancer. DOI 10.3390/pharmaceutics12060576 ↗
- Paper [Comparison of therapeutic peptides targeting pancreatic cancer]. PMID 31821385 ↗
László Kőhidai · 2 shared papers, 2019–2020
- Paper Phage Display-Based Homing Peptide-Daunomycin Conjugates for Selective Drug Targeting to PANC-1 Pancreatic Cancer. DOI 10.3390/pharmaceutics12060576 ↗
- Paper [Comparison of therapeutic peptides targeting pancreatic cancer]. PMID 31821385 ↗
Zsófia A. Szász · 1 shared paper, 2019
- Paper [Comparison of therapeutic peptides targeting pancreatic cancer]. PMID 31821385 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.